טוען...
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation
Ewing sarcoma is the second most common solid bone malignancy diagnosed in pediatric and young adolescent populations. Despite global co-operative efforts, outcomes for patients with relapsed and refractory disease remains obstinately poor. It has become increasingly clear that disruption of the epi...
שמור ב:
| הוצא לאור ב: | Oncotarget |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Impact Journals LLC
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6284858/ https://ncbi.nlm.nih.gov/pubmed/30559927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26326 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|